Hedy P Smith, MD

Clinical Associate Professor, Medicine

Hedy Smith
(617) 638-5723
820 Harrison Avenue


  • Published on 10/3/2013

    Kutlar A, Reid ME, Inati A, Taher AT, Abboud MR, El-Beshlawy A, Buchanan GR, Smith H, Ataga KI, Perrine SP, Ghalie RG. A dose-escalation phase IIa study of 2,2-dimethylbutyrate (HQK-1001), an oral fetal globin inducer, in sickle cell disease. Am J Hematol. 2013 Nov; 88(11):E255-60. PMID: 23828223.

    Read at: PubMed
  • Published on 10/13/2006

    Andersson BA, Wering ME, Luo HY, Basran RK, Steinberg MH, Smith HP, Chui DH. Sickle cell disease due to compound heterozygosity for Hb S and a novel 7.7-kb beta-globin gene deletion. Eur J Haematol. 2007 Jan; 78(1):82-5. PMID: 17038017.

    Read at: PubMed

View all profiles